• Author: Stephen J. Freedland
Clear all

Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. Veterans cohort

Abstract: BACKGROUND: The Prostatype® Test evaluates expression levels of three stem cell genes (IGFBP3, F3, and VGLL3), which are combined with PSA, stage, and grade to calculate …

Racial differences in adverse events after androgen deprivation in Veterans with prostate cancer

Abstract: Importance: Androgen deprivation therapy (ADT) for prostate cancer (PC) has been linked to adverse events, such as cardiac events and osteoporosis. Whether these …

Retrospective analysis of racial differences in treatment patterns and prostate-specific antigen responses among patients with prostate cancer treated with Relugolix in the Veterans Health Administration

Abstract: Introduction: Relugolix is the only oral androgen deprivation therapy (ADT) approved for advanced prostate cancer (PC). Real-world evidence on treatment patterns and …

Sex differences in cystoscopic findings among Veterans with interstitial cystitis

Abstract:Purpose: Previous studies have found significant sex differences in symptoms among patients with interstitial cystitis/bladder pain syndrome (IC/BPS). However, whether …

Racial and ethnic differences in prostate cancer epidemiology across disease states in the VA

Abstract: Importance: Prostate cancer (PC) care has evolved rapidly as a result of changes in prostate-specific antigen testing, novel imaging, and newer treatments. The impact of …

Real-world evidence of 18F-fluciclovine positron emission tomography/computed tomography performance for recurrent prostate cancer in the Veterans Affairs Health System

Abstract: Background: There are no population-level studies assessing (18)F-fluciclovine (fluciclovine) utilization of Positron emission tomography/computed tomography (PET/CT) for …

Racial Disparities in Stage at Bladder Cancer Diagnosis in the US Veterans Affairs Healthcare System

Abstract: Objective: To describe patient characteristics and pathological stage at bladder cancer (BCa) diagnosis in a diverse population within a national, equal-access healthcare …